威奧股份(605001.SH)擬3.087億元出售賽史品威奧50.6%股權
格隆匯12月14日丨威奧股份(605001.SH)公佈,為整合公司資源,優化公司資源配置,公司擬將其持有的賽史品威奧50.60%的股權轉讓給帝人中國。2020年12月14日,公司和帝人中國就本次交易簽訂《賽史品威奧(唐山)結構複合材料有限公司之股權轉讓協議》。經雙方協商一致同意,本次交易對價為人民幣3.087億元。
賽史品威奧主要從事汽車輕量化材料及車身覆蓋件和高強度結構類部件的研發、生產和銷售。該項業務與公司的主營業務即軌道交通配套產業鮮有交集。本次出售賽史品威奧股權是公司剝離非核心資產、整合資源、優化公司資源配置的舉措之一,有利於公司聚焦主業,提升產業競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.